C

Concord Biotech Ltd

PharmaceuticalsSmallcap

About the company

Concord Biotech Limited, a biopharma company, engages in R&D, manufacturing, and marketing of pharmaceutical products in diverse therapeutic segments.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 4 analysts offering recommendations for Concord Biotech Ltd

75%

Buy

25%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio51.5741.83
PB Ratio7.426.25
Dividend Yield0.59%0.55%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions